1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001773:Blood Cells / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D004247:DNA / Q000096:biosynthesis; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004988:Ethers, Cyclic / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity; D007928:Lethal Dose 50; D008353:Mannitol / Q000494:pharmacology; D008698:Mesylates / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D051381:Rats; D013402:Sugar Alcohols / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D004988:Ethers, Cyclic; D008698:Mesylates; D012334:RNA, Neoplasm; D013402:Sugar Alcohols; D008353:Mannitol; D012313:RNA; D004247:DNA